Dare Bioscience Inc logo

Dare Bioscience Inc

NEW
NAS:DARE (USA)  
$ 4.16 0 (0%) 07:08 PM EST
0.27
P/B:
13.65
Market Cap:
$ 36.15M
Enterprise V:
$ 21.69M
Volume:
68.29K
Avg Vol (2M):
34.55K
Trade In:
Volume:
68.29K
Avg Vol (2M):
34.55K

Business Description

Description
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Name Current Vs Industry Vs History
Cash-To-Debt 10.76
Equity-to-Asset 0.11
Debt-to-Equity 0.57
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.31
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 86.46
9-Day RSI 80.44
14-Day RSI 74.99
6-1 Month Momentum % -12.2
12-1 Month Momentum % -36.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.43
Quick Ratio 1.43
Cash Ratio 1.13
Days Payable 217592.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34
Shareholder Yield % -27.47

Financials (Next Earnings Date:2024-11-08 Est.)

DARE's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DARE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Dare Bioscience Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.839
EPS (TTM) ($) 15.6
Beta 1.3
Volatility % 103.31
14-Day RSI 74.99
14-Day ATR ($) 0.194076
20-Day SMA ($) 3.55497
12-1 Month Momentum % -36.92
52-Week Range ($) 3.05 - 7.56
Shares Outstanding (Mil) 8.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Dare Bioscience Inc Filings

Filing Date Document Date Form
No Filing Data

Dare Bioscience Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Dare Bioscience Inc Frequently Asked Questions

What is Dare Bioscience Inc(DARE)'s stock price today?
The current price of DARE is $4.16. The 52 week high of DARE is $7.56 and 52 week low is $3.05.
When is next earnings date of Dare Bioscience Inc(DARE)?
The next earnings date of Dare Bioscience Inc(DARE) is 2024-11-08 Est..
Does Dare Bioscience Inc(DARE) pay dividends? If so, how much?
Dare Bioscience Inc(DARE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1